Etna Abad

5PUBLICATIONS
28CO-AUTHORS
Cancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 08, 2026
PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunity.

|Nov 30, 2021
Movement of Mitochondria with Mutant DNA through Extracellular Vesicles Helps Cancer Cells Acquire Chemoresistance.

Etna Abad, Alex Lyakhovich

|Apr 30, 2021
Triphenilphosphonium Analogs of Chloramphenicol as Dual-Acting Antimicrobial and Antiproliferating Agents.

Julia A Pavlova, Zimfira Z Khairullina, Andrey G Tereshchenkov

|Oct 22, 2020
Enhanced DNA damage response through RAD50 in triple negative breast cancer resistant and cancer stem-like cells contributes to chemoresistance.

Etna Abad, Laia Civit, David Potesil

|Oct 21, 2020
Consequences of Zmat3 loss in c-MYC- and mutant KRAS-driven tumorigenesis.

Sarah A Best, Cassandra J Vandenberg, Etna Abad

Pageof 1

Frequent Collaborators

3 joint publications

Alex Lyakhovich

2 joint publications

Ana Janic

1 joint publications

Sarah A Best

1 joint publications

Cassandra J Vandenberg